Planar-Chiral Metalloligands
Organometallics, Vol. 26, No. 25, 2007 6425
2
C7-H), 6.86-6.81 (m, 2H, C5-H and C6-H), 4.67 (s, 1H, C1-H),
2.58 (s, 6H, NMe2), 2.57-2.43 (m, 2H, P(CHMecMed) and
Cl2): δ 131.2 (d, JPC ) 24.3 Hz, C2), 125.4 (C7 or C4), 125.0
(aryl CH), 124.5 (aryl CH), 123.9 (aryl CH), 106.6 (br s, COD),
101.8 (br s, COD), 96.9 (d, JPC ) 3.9 Hz, C3a or C7a), 88.1 (C7a
3
P(CHMeaMeb)), 1.57 (s, 15H, C5Me5), 1.36 (d of d, JPH ) 11.5
3
1
Hz, JHH ) 7.0 Hz, 3H, P(CHMecMed)), 1.33-1.25 (m, 6H,
or C3a), 84.8 (C5Me5), 76.2 (m, COD), 69.6 (COD), 69.2 (d, JPC
P(CHMeaMeb)), 1.18 (d of d, 3JPH ) 16.0 Hz, 3JHH ) 7.5 Hz, 3H,
P(CHMedMec)). 13C{1H} NMR (C6D6): δ 128.0 (C4 or C7), 127.3
(d, 2JPC ) 6.5 Hz, C2), 124.7 (C7 or C4), 121.9 (C5 or C6), 120.6
(C6 or C5), 94.0 (d, JPC ) 10.1 Hz, C3a or C7a), 91.3 (C7a or
C3a), 82.1 (C5Me5), 70.6 (d, 1JPC ) 31.8 Hz, C3), 63.3 (C1), 46.8
) 52.5 Hz, C3), 61.1 (d, JPC ) 8.8 Hz, C1), 54.8 (br s, NMe2)
3
34.4 (br s, COD), 30.4 (br s, COD), 26.2-26.1 (P(CHMeaMeb)
1
and COD), 25.5 (d, JPC ) 26.0 Hz, P(CHMecMed)), 20.8
2
(P(CHMedMec)), 20.1 (d, JPC ) 4.0 Hz, P(CHMeaMeb)), 19.4 (d,
2JPC ) 3.7 Hz, P(CHMedMec)), 18.2 (P(CHMeaMeb)), 10.1 (C5Me5).
4
1
1
(d, JPC ) 6.7 Hz, NMe2), 24.3 (d, JPC ) 13.1 Hz, P(CHMec-
31P{1H} NMR (CD2Cl2): δ 42.4 (d, JPRh ) 150.6 Hz).
1
2
Synthesis of [4b]+BF4-. To a glass vial containing a magneti-
cally stirred suspension of [(COD)RhCl]2 (0.025 g, 0.050 mmol)
in THF (2 mL) was added a suspension of AgBF4 (0.020 g, 0.10
mmol) in THF (2 mL); a yellow solution was generated immediately
along with a white precipitate. The supernatant solution was
separated from the precipitate by filtration through Celite, and the
solution was transferred to a glass vial containing a magnetically
stirred solution of 3b (0.051 g, 0.10 mmol) in THF (3 mL). The
reaction mixture was stirred for an additional 3 h at ambient
temperature, during which time the solution developed a yellow-
orange coloration. The reaction mixture was then filtered through
a plug of Celite, followed by removal of the solvent and other
Med)), 23.7 (d, JPC ) 13.1 Hz, P(CHMeaMeb)), 23.3 (d, JPC
)
23.1 Hz, P(CHMedMec)), 22.9 (d, 2JPC ) 20.8 Hz, P(CHMeaMeb)),
21.5 (d, 2JPC ) 18.9 Hz, P(CHMeaMeb)), 20.7 (d, 2JPC ) 11.1 Hz,
P(CHMedMec)), 10.8 (C5Me5). 31P{1H} NMR (C6D6): δ -0.3.
Crystals of 3b suitable for single-crystal X-ray diffraction analysis
were grown from pentane at -35 °C.
Synthesis of 3c. A vial charged with a stir bar and a solution of
Cp*FeCl (1.10 mmol) in THF (2 mL) (prepared in a manner
analogous to that described for the synthesis of 2c) was cooled to
-35 °C. To this solution was added slowly a solution of 1a[Li]
(1.10 mmol) and THF (2 mL) (precooled to -35 °C), and the
mixture was stirred magnetically at ambient temperature for 2 h.
The solvent and other volatile materials were removed in vacuo,
and the residue was taken up in pentane (5 mL) followed by
filtration through a short plug of Celite. The filtrate was collected,
and the solvent and other volatile materials were removed in vacuo.
Any decamethylferrocene that was produced during the synthesis
was then removed via sublimation to leave 3c as an analytically
pure, purple solid (0.31 g, 0.68 mmol, 62%). Anal. Calcd for C27H40-
PNFe: C, 69.57; H, 8.66; N, 3.01. Found: C, 69.57; H, 8.50; N,
-
volatiles in vacuo yielding [4b]+BF4 as a orange solid (0.078 g,
0.096 mmol, 96%). Anal. Calcd for C35H52PNRuRhBF4: C, 51.96;
H, 6.48; N, 1.73. Found: C, 51.84; H, 6.45; N, 1.75. H NMR
(CD2Cl2): δ 7.19 (d, JHH ) 8.5 Hz, 1H, C7-H or C4-H), 7.14-
1
3
7.05 (m, 3H, aryl CH), 5.42 (br s, 1H, COD), 5.19 (s, 1H, C1-H),
4.87 (m, 1H, COD), 4.53 (m, 1H, COD), 3.90 (m, 1H, COD), 3.21
(s, 3H, NMe), 2.80 (s, 3H, NMe), 2.75-2.20 (m, 9H, P(CHMec-
3
Med), P(CHMeaMeb), and COD), 2.01 (d of d, JPH ) 18.0 Hz,
1
3
2.96. H NMR (C6D6): δ 7.77 (d, JHH ) 8.4 Hz, 1H, C7-H or
3JHH ) 7.5 Hz, 3H, P(CHMecMed)), 1.95 (m, 1H, COD), 1.63 (d
of d, 3JPH ) 14.0 Hz, 3JHH ) 7.0 Hz, 3H, P(CHMecMed)), 1.59 (s,
3
C4-H), 7.22 (d, JHH ) 8.0 Hz, 1H, C4-H or C7-H), 6.95-7.02
(m, 2H, C5-H and C6-H), 4.24 (s, 1H, C1-H), 2.63 (s, 6H, NMe2),
3
3
15H, C5Me5), 1.19 (d of d, JPH ) 15.0 Hz, JHH ) 7.5 Hz, 3H,
P(CHMeaMeb)), 0.99 (d of d, 3JPH ) 17.0 Hz, 3JHH ) 7.0 Hz, 3H,
P(CHMeaMeb)). 13C{1H} NMR (CD2Cl2): δ 131.1 (d, 2JPC ) 24.3
Hz, C2), 125.5 (C4 or C7), 125.0 (aryl CH), 124.6 (aryl CH), 124.0
(aryl CH), 106.7 (m, COD), 101.7 (m, COD), 97.0 (C3a or C7a),
88.2 (C7a or C3a), 84.9 (C5Me5), 76.1 (d, J ) 12.7 Hz, COD),
69.7 (d, J ) 12.0 Hz, COD), 69.2 (d, 1JPC ) 32.5 Hz, C3), 60.8 (d,
J ) 8.8 Hz, C1), 55.1 (NMe), 54.0 (NMe), 34.4 (COD), 30.4
(COD), 26.2 (d, 1JPC ) 23.0 Hz, P(CHMecMed)), 26.1 (COD), 25.5
2.53-2.62 (m, 2H, P(CHMecMed) and P(CHMeaMeb)), 1.58 (s,
3
3
15H, C5Me5), 1.58 (d of d, JPH ) 10.3 Hz, JHH ) 7.0 Hz, 3H,
P(CHMeaMeb)), 1.30 (d of d, 3JPH ) 13.7 Hz, 3JHH ) 6.9 Hz, 3H,
P(CHMebMea)), 1.19 (d of d, 3JPH ) 11.3 Hz, 3JHH ) 7.4 Hz, 3H,
3
3
P(CHMecMed)), 1.15 (d of d, JPH ) 7.1 Hz, JHH ) 2.6 Hz, 3H,
P(CHMedMec)). 13C{1H} NMR (C6D6): δ 130.1 (C4 or C7), 123.5
2
(C5 or C6), 122.3 (C6 or C5), 120.6 (d, JPC ) 4.4 Hz, C2), 89.8
(d, JPC ) 12.2 Hz, C3a or C7a), 87.8 (C7a or C3a), 76.8 (C5Me5),
1
4
1
63.3 (d, JPC ) 31.1 Hz, C3), 75.7 (C1), 46.3 (d, JPC ) 6.4 Hz,
(d, JPC ) 25.8 Hz, P(CHMeaMeb)), 20.8 (P(CHMecMed)), 20.1
NMe2), 23.6 (d, 1JPC ) 25.7 Hz, P(CHMecMed) or P(CHMecMed)),
(P(CHMeaMeb)), 19.4 (P(CHMecMed)), 18.2 (P(CHMeaMeb)), 10.0
1
1
23.3 (d, JPC ) 13.8 Hz, P(CHMeaMeb) or P(CHMecMed)), 22.9
(C5Me5). 31P{1H} NMR (CD2Cl2): δ 42.5 (d, JPRh ) 150.4 Hz).
1
Synthesis of [4a]+BF4-. A procedure analogous to that described
(d, JPC ) 11.9 Hz, (P(CHMedMec) or P(CHMeaMeb)), 22.7 (d,
2JPC ) 4.0 Hz, P(CHMecMed) or P(CHMecMed)), 21.5 (d, JPC
)
2
-
for the synthesis of [4b]+BF4 was employed, using 3a (0.015 g,
2
0.037 mmol) in THF (1 mL). Complex [4a]+BF4- was isolated as
a dark yellow solid (0.023 g, 0.032 mmol, 87%). Anal. Calcd for
C28H37PNMnO3RhBF4: C, 47.25; H, 5.24; N, 1.97. Found: C,
47.41; H, 5.62; N, 1.83. 1H NMR (CD2Cl2): δ 7.72 (d, 3JHH ) 8.3
Hz, 1H, C7-H or C4-H), 7.49-7.42 (m, 2H, aryl CH), 7.29 (t, 3JHH
) 7.4 Hz, C6-H or C5-H), 6.05 (s, 1H, C1-H), 5.60 (br s, 1H,
COD), 4.94 (br s, 1H, COD), 4.66 (br s, 1H, COD), 3.94 (br s, 1H,
COD), 3.39 (s, 3H, NMe), 2.81 (s, 3H, NMe), 2.81-2.68 (m, 4H,
P(CHMecMed), P(CHMebMea), and COD), 2.47 (m, 1H, COD),
2.39-2.31 (m, 2H, COD), 2.01-1.93 (m, 5H, COD and P(CH-
MecMed)), 1.89-1.85 (m, 4H, P(CHMecMed) and COD), 1.34 (d
of d, 3JPH ) 15.3 Hz, 3JHH ) 7.0 Hz, 3H, P(CHMeaMeb)), 1.22 (d
of d, 3JPH ) 16.9 Hz, 3JHH ) 6.9 Hz, 3H, P(CHMeaMed)). 13C{1H}
19.1 Hz, P(CHMebMea)), 20.2 (d, JPC ) 8.0 Hz, P(CHMebMea)),
10.2 (C5Me5). 31P{1H} NMR (C6D6): δ -2.5.
Synthesis of [4b]+Cl-. To a glass vial charged with a stir bar,
3b (0.12 g, 0.24 mmol), and THF (2 mL) was added a solution of
[(COD)RhCl]2 (0.059 g, 0.12 mmol) in THF (4 mL). The mixture
was stirred for 4 h at ambient temperature, and during this time a
precipitate formed. The supernatant was decanted, and the precipi-
tate was washed with THF (5 mL). The residue was then dried in
vacuo, affording analytically pure [4b]+Cl- as a yellow solid (0.088
g, 0.12 mmol, 49%). Anal. Calcd for C35H52PNRuRhCl: C, 55.50;
1
H, 6.93; N, 1.85. Found: C, 55.22; H, 6.77; N, 1.53. H NMR
3
(CD2Cl2): δ 7.17 (d, JHH ) 8.5 Hz, 1H, C7-H or C4-H), 7.12-
7.00 (m, 3H, aryl CH), 5.38 (br s, 1H, COD), 5.24 (s, 1H, C1-H),
4.82 (br s, 1H, COD), 4.55 (br s, 1H, COD), 3.84 (br s, 1H, COD),
3.20-2.80 (br m, 6H, NMe2), 2.69-2.45 (m, 4H, P(CHMecMed),
P(CHMeaMeb) and COD), 2.40-2.21 (m, 4H, COD), 1.96 (d of d,
2
NMR (CD2Cl2): δ 223.2 (CO), 141.5 (d, JPC ) 21.4 Hz, C2),
130.5 (aryl CH), 129.1 (C4 or C7), 127.3 (C5 or C6), 122.8 (aryl
CH), 108.0 (t, J ) 7.4 Hz, COD), 102.5 (COD), 100.9 (m, aryl C),
77.4 (d, J ) 12.5 Hz, COD), 71.3 (d, J ) 12.5 Hz, COD), 68.3 (d,
3JPC ) 11.7 Hz, C1), 56.6 (NMe), 50.6 (NMe), 35.1 (COD), 30.6
3
3JHH ) 7.5 Hz, JPH ) 17.5 Hz, 3H, P(CHMedMec)), 1.99-1.82
3
3
(m, 2H, COD), 1.59 (d of d, JHH ) 7.0 Hz, JPH ) 14.0 Hz, 3H,
3
1
P(CHMedMec)), 1.55 (s, 15H, C5Me5), 1.15 (d of d, JHH ) 7.0
(COD), 29.6 (COD), 27.6 (d, JPC ) 22.6 Hz, P(CHMecMed) or
P(CHMeaMeb)), 25.8 (P(CHMeaMeb) or P(CHMecMed)), 25.6
(COD), 22.7 (P(CHMeaMeb)), 20.1 (d, JPC ) 3.2 Hz, (P(CHMec-
Hz, 3JPH ) 15.0 Hz, 3H, P(CHMebMea)), 0.94 (d of d, 3JHH ) 7.5
Hz, JPH ) 17.5 Hz, 3H, P(CHMebMea)). 13C{1H} NMR (CD2-
3
2